180 related articles for article (PubMed ID: 35432170)
1. Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study.
Pellesi L; Al-Karagholi MA; De Icco R; Chaudhry BA; Lopez CL; Snellman J; Hannibal J; Amin FM; Ashina M
Front Neurol; 2022; 13():871176. PubMed ID: 35432170
[TBL] [Abstract][Full Text] [Related]
2. PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation.
Pellesi L; Chaudhry BA; Vollesen ALH; Snoer AH; Baumann K; Skov PS; Jensen RH; Ashina M
Cephalalgia; 2022 Jul; 42(8):687-695. PubMed ID: 34822741
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study.
Deligianni C; Pellesi L; Chaudhry BA; Haulund Vollesen AL; Snoer AH; Hannibal J; Jensen RH; Ashina M
Front Neurol; 2023; 14():1135246. PubMed ID: 37143998
[TBL] [Abstract][Full Text] [Related]
4. Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.
Guo S; Vollesen AL; Hansen YB; Frandsen E; Andersen MR; Amin FM; Fahrenkrug J; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):136-147. PubMed ID: 26994298
[TBL] [Abstract][Full Text] [Related]
5. The role of genetics on migraine induction triggered by CGRP and PACAP38.
Guo S
Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260603
[TBL] [Abstract][Full Text] [Related]
6. Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial.
Pellesi L; Al-Karagholi MA; De Icco R; Coskun H; Elbahi FA; Lopez-Lopez C; Snellman J; Hannibal J; Amin FM; Ashina M
JAMA Netw Open; 2021 Aug; 4(8):e2118543. PubMed ID: 34357396
[TBL] [Abstract][Full Text] [Related]
7. The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study.
Rasmussen NB; Deligianni C; Christensen CE; Karlsson WK; Al-Khazali HM; Van de Casteele T; Granhall C; Amin FM; Ashina M
J Headache Pain; 2023 May; 24(1):60. PubMed ID: 37231350
[TBL] [Abstract][Full Text] [Related]
8. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Bellamy JL; Cady RK; Durham PL
Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
[TBL] [Abstract][Full Text] [Related]
9. Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers.
Pellesi L; Al-Karagholi MA; Chaudhry BA; Lopez CL; Snellman J; Hannibal J; Amin FM; Ashina M
Cephalalgia; 2020 Oct; 40(11):1212-1223. PubMed ID: 32594760
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38.
Amin FM; Hougaard A; Schytz HW; Asghar MS; Lundholm E; Parvaiz AI; de Koning PJ; Andersen MR; Larsson HB; Fahrenkrug J; Olesen J; Ashina M
Brain; 2014 Mar; 137(Pt 3):779-94. PubMed ID: 24501094
[TBL] [Abstract][Full Text] [Related]
11. PACAP38 induces migraine-like attacks in patients with migraine without aura.
Schytz HW; Birk S; Wienecke T; Kruuse C; Olesen J; Ashina M
Brain; 2009 Jan; 132(Pt 1):16-25. PubMed ID: 19052139
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: A study in chronic migraine patients.
Riesco N; Cernuda-Morollón E; Martínez-Camblor P; Pérez-Alvarez AI; Verano L; García-Cabo C; Serrano-Pertierra E; Pascual J
Cephalalgia; 2017 Aug; 37(9):823-827. PubMed ID: 27250233
[TBL] [Abstract][Full Text] [Related]
13. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
[TBL] [Abstract][Full Text] [Related]
14. Sumatriptan Does Not Antagonize CGRP-Induced Symptoms in Healthy Volunteers.
Falkenberg K; Rønde Bjerg H; Yamani N; Olesen J
Headache; 2020 Apr; 60(4):665-676. PubMed ID: 31944310
[TBL] [Abstract][Full Text] [Related]
15. An exploratory analysis of clinical and sociodemographic factors in CGRP-induced migraine attacks: A REFORM study.
Al-Khazali HM; Ashina H; Christensen RH; Wiggers A; Rose K; Iljazi A; Schytz HW; Amin FM; Ashina M
Cephalalgia; 2023 Oct; 43(10):3331024231206375. PubMed ID: 37815254
[TBL] [Abstract][Full Text] [Related]
16. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin-gene related peptide and disease activity in cluster headache.
Snoer A; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Fahrenkrug J; Jørgensen NR; Martinussen T; Jensen RH; Ashina M
Cephalalgia; 2019 Apr; 39(5):575-584. PubMed ID: 30854880
[TBL] [Abstract][Full Text] [Related]
18. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide causes migraine aura.
Al-Khazali HM; Ashina H; Wiggers A; Rose K; Iljazi A; Christensen RH; Schytz HW; Amin FM; Ashina M
J Headache Pain; 2023 Sep; 24(1):124. PubMed ID: 37679723
[TBL] [Abstract][Full Text] [Related]
20. Investigation of carbachol and PACAP38 in a human model of migraine.
Schytz HW
Dan Med Bull; 2010 Dec; 57(12):B4223. PubMed ID: 21122466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
